Hacker News
- How a Drug Company Made $114B by Gaming the U.S. Patent System https://www.nytimes.com/2023/01/28/business/humira-abbvie-monopoly.html 29 comments
- How a Drug Company Made $114 Billion by Gaming the U.S. Patent System https://www.nytimes.com/2023/01/28/business/humira-abbvie-monopoly.html 11 comments business
- How a Drug Company Made $114 Billion by Gaming the U.S. Patent System https://www.nytimes.com/2023/01/28/business/humira-abbvie-monopoly.html 10 comments economy
- How a Drug Company Made $114 Billion by Gaming the U.S. Patent System https://www.nytimes.com/2023/01/28/business/humira-abbvie-monopoly.html 28 comments business
Linking pages
- Six Reasons Drug Prices Are So High in the U.S. - The New York Times https://www.nytimes.com/2024/01/17/health/us-drug-prices.html 90 comments
- How PBMs Are Driving Up Prescription Drug Costs - The New York Times https://www.nytimes.com/2024/06/21/business/prescription-drug-costs-pbm.html 76 comments
- Six Ways Existing Economic Models Are Killing the Economy - The American Prospect https://prospect.org/economy/2023-04-05-six-ways-economic-models-killing-economy/ 8 comments
Linked pages
- Democrats’ Long-Sought Plan for Lowering Drug Costs Is at Hand - The New York Times https://www.nytimes.com/2022/08/05/us/politics/medicare-drug-costs.html 300 comments
- A three-decade monopoly: how Amgen built a patent thicket around its top-selling drug | BioPharma Dive https://www.biopharmadive.com/news/amgen-enbrel-patent-thicket-monopoly-biosimilar/609042/ 0 comments
Related searches:
Search whole site: site:www.nytimes.com
Search title: How a Drug Company Made $114 Billion by Gaming the U.S. Patent System - The New York Times
See how to search.